Press Releases

There are currently no events to display.
Date Title  
02/25/20
Lantheus Holdings, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results
Worldwide revenue of $89.3 million and $347.3 million for the fourth quarter and full year 2019, representing an increase of 3.6% and 1.2% over the prior year period, respectively Net income of $10.5 million and $31.7 million for the fourth quarter and full year 2019, representing a decrease of
02/20/20
Lantheus and Progenics Agree to Amended Transaction Terms
Combination to Create Robust Portfolio and Pipeline of Precision Diagnostic and Therapeutic Products Progenics Shareholders Will Receive 0.31 Shares of Lantheus Common Stock for Each Share of Progenics Stock in All-Stock Transaction, Represents Approximately 40% Ownership Stake in Combined Company
02/18/20
Lantheus Holdings to Present at the 9th Annual SVB Leerink Global Healthcare Conference
NORTH BILLERICA, Mass. --(BUSINESS WIRE)--Feb. 18, 2020-- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products,
02/18/20
Lantheus Holdings to Host Fourth Quarter and Full Year 2019 Earnings Conference Call on February 25, 2020 at 8:00 a.m. Eastern Time
NORTH BILLERICA, Mass. --(BUSINESS WIRE)--Feb. 18, 2020-- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call at 8:00 a.m. ET on Tuesday, February 25, 2020 , to discuss its financial and operating results for the fourth quarter and full year of
02/03/20
Lantheus Announces Topline Results for BENEFIT 1 LVEF Clinical Trial
NORTH BILLERICA, Mass. --(BUSINESS WIRE)--Feb. 3, 2020-- Lantheus Holdings, Inc. (NASDAQ: LNTH) (“Lantheus” or the “Company”), parent company of Lantheus Medical Imaging, Inc. (“LMI”), a leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and
01/27/20
Lantheus Holdings Announces Senior Leadership Appointment
Company Appoints Paul Blanchfield as Chief Commercial Officer NORTH BILLERICA, Mass. --(BUSINESS WIRE)--Jan. 27, 2020-- Lantheus Holdings, Inc. (NASDAQ: LNTH) (“Lantheus”), parent company of Lantheus Medical Imaging, Inc. (“LMI”), a leader in the development, manufacture and commercialization of
01/13/20
Lantheus Holdings Announces Senior Leadership Appointment
Company Appoints Istvan Molnar, M.D. as Chief Medical Officer NORTH BILLERICA, Mass. --(BUSINESS WIRE)--Jan. 13, 2020-- Lantheus Holdings, Inc. (NASDAQ: LNTH) (“Lantheus”), parent company of Lantheus Medical Imaging, Inc. (“LMI”), a leader in the development, manufacture and commercialization of